What is the main business of LM Line?

The main business activity of LM Line focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 11, 2006.

Where is the headquarters located?

The headquarters is located at: Kniewska 2K, 70-846 Szczecin.

What is the share capital?

The share capital of the company is PLN 90,000 (approx. $24,311).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $3,541,531, representing an increase of 22.8% compared to 2024.

Yes, the company recorded a net profit of $355,559 in 2025, meaning the company increased its profit by 32.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $1,792,501 in 2025, representing 58% of all operating expenses.

LM Linesp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2006-01-11

Share capital

90 000,00 PLN

Activity description

Lm Line is a professional supplier of medical diagnostic equipment, providing a wide range of products including multi-use and single-use sensors, EKG cables, blood pressure cuffs, and various medical accessories. The company also offers devices such as pulse oximeters, ECG machines, and defibrillators, catering to the healthcare industry since 2004.

Registered address

Kniewska 2K, 70-846 Szczecin, Poland

Website

lmline.pl

Phone

Social media

Electronic delivery address

AE:PL-64950-70473-IVGID-16

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 3.54mMedianUSD 873.84kAverageUSD 20.03m

Net profit

This companyUSD 355.56kMedianUSD 28.21kAverageUSD 815.54k

Operating costs

This companyUSD 3.07mMedianUSD 801.08kAverageUSD 18.78m

Assets

This companyUSD 1.45mMedianUSD 539.29kAverageUSD 10.66m

Industry

Bank accounts

Registered as a VAT taxpayer on 2005-01-04. Active

Alior Bank
77 2490 0005 0000 4600 7040 4259
Alior Bank
89 2490 0005 0000 4600 3449 9687
Alior Bank
49 2490 0005 0000 4530 8020 2874

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
Jul 22, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,108	Prezes Zakładu Ubezpieczeń Społecznych
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,868	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,094	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

215 tenders recorded as contractor: 91 national ($1,579,041) and 124 EU ($31,041,145).

Publication date	Subject	Amount	Contracting authority
Sep 30, 2026	Sprzedaż i dostawa sprzętu jednorazowego.	—	Samodzielny Szpital Wojewódzki Im.Mikołaja Kopernika w Piotrkowie Trybunalskim
Sep 25, 2026	Dostawa części zużywalnych do aparatury medycznej - 21 zadań	—	Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie
Sep 25, 2026	Dostawa części zużywalnych do aparatury medycznej - 21 zadań	—	Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie

Authorized Representatives

Srikanth Apputhurai — Vice President of the Management Board

Dariusz Krzysztof Szczęsny — Attorney-in-fact (sole)

Jarosław Haśkiewicz — Attorney-in-fact (sole)

Per Laursen — President of the Management Board

Manner of representation

Joint action by all members of the management board is required to make declarations of will on behalf of the company and to represent it externally.

Ownership

Owner	Shares	Share value	Stake
Laursen Holding Aps	346	$9,346.30	38.4444%
Mathan Holding Aps	338	$9,130.20	37.5556%
Dariusz Krzysztof Szczęsny (51)	135	$3,646.68	15%
Others	81	$2,188.01	9%

Beneficial owners

Person	Rights
Srikanth Apputhurai (49)	Posiadanie 100% udziałów w mathan holding aps posiadającej 37,6% udziałów w lm line sp. z o.o. o wartości 33'800 zł
Per Laursen (72)	Posiadanie 100% udziałów w laursen holding aps posiadającej 37,6% udziałów w lm line sp. z o.o. o wartości 34'600 zł

Competitors

Name	Revenue	Website
Medicavera Dahlhausen Groupsp. z o.o.	$7,393,838.95	medicavera.pl
Przedsiębiorstwo Handlowe Linessp. z o.o.	$5,548,056.66	lines.com.pl
Medcomplexsp. z o.o.	$5,193,830.09	medcomplex.pl
Medmess Kropaczewskisp. k.	$4,516,614.15	medmess.pl
Reynolds Medicalsp. z o.o.	$3,313,657.78	reymed.pl
Dasmedicsp. z o.o.	$2,979,267.48	dasmedic.pl
Mikamedsp. z o.o.	$1,938,472.05	mikamed.pl
OMET Medicalsp. z o.o.	$1,867,545.06	ometmedical.pl
Passimedsp. z o.o.	$1,677,642.39	passimed.pl
Optimed Pro-Office Cirrosp. j.	$1,276,876.90	cirro.pl

Change history

Date	Event
2016-10-26	PKD change (Removed: 51.43.Z, 51.46.Z, 52.32.Z, 52.44.Z; Added: 33.12.Z, 33.13.Z, 33.14.Z, 33.20.Z, 46.46.Z, 46.47.Z, 46.69.Z, 47.59.Z, 47.74.Z, 62.09.Z)
2009-07-31	Address change (Raciborska 1, 70-853, Szczecin → Kniewska 2k, 70-846, Szczecin)
2007-09-03	Address change (Szybowcowa 28, 70-843, Szczecin → Raciborska 1, 70-853, Szczecin)
2006-01-11	Entered in the register

FAQ

Last updated: 2026-07-17